TYPE-2 NEUROFIBROMATOSIS - THE NEED FOR SUPRAREGIONAL CARE

被引:42
|
作者
EVANS, DGR
RAMSDEN, R
HUSON, SM
HARRIS, R
LYE, R
KING, TT
机构
[1] MANCHESTER ROYAL INFIRM, DEPT OTOLARYNGOL, MANCHESTER M13 9WL, LANCS, ENGLAND
[2] CHURCHILL HOSP, DEPT MED GENET, OXFORD OX3 7LJ, ENGLAND
[3] MANCHESTER ROYAL INFIRM, DEPT NEUROSURG, MANCHESTER M13 9WL, LANCS, ENGLAND
[4] LONDON HOSP, DEPT NEUROSURG, LONDON E1 1BB, ENGLAND
关键词
NEUROFIBROMATOSIS; CENTRAL; NF2;
D O I
10.1017/S002221510012328X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The results of a U.K. study of 145 cases of type 2 neurofibromatosis has shown generally very poor operative results in terms of hearing and facial nerve preservation. Only 9 out of 118 vestibular schwannoma (acoustic neuroma) operations resulted in any clinically detectable hearing preservation and only 32 left the patient with good or normal (House grade I or II) ipsilateral facial nerve function. Although operation is still the definitive treatment of vestibular schwannoma (acoustic neuroma) and may be a lifesaving procedure, it appears that the evidence in favour of early operation is only valid when carried out in highly specialized centres. The special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf warrants a careful experienced approach. Timing of operations may be critical for the enhancement of useful years of quality life. We therefore propose the setting up of a national NF2 register, with the management of cases at a few supraregional centres.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [31] Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2
    Kida, Y
    Kobayashi, T
    Tanaka, T
    Mori, Y
    SURGICAL NEUROLOGY, 2000, 53 (04): : 383 - 389
  • [32] Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2
    Seo, Stefanie
    Shen, Sarek
    Ding, Andy S.
    Creighton, Francis X.
    LARYNGOSCOPE, 2024, 134 (04) : 1847 - 1853
  • [33] A clinical study of vestibular schwannomas in type 2 neurofibromatosis
    Kishore, A
    O'Reilly, BF
    CLINICAL OTOLARYNGOLOGY, 2000, 25 (06) : 561 - 565
  • [34] Unusual fundus lesion in mosaic neurofibromatosis type 2
    Berry, Michael H.
    Skanchy, David F.
    Archer, Steven M.
    Mingardo, Federica
    Elner, Victor
    Demirci, Hakan
    OPHTHALMIC GENETICS, 2025, : 211 - 214
  • [35] Neurofibromatosis type 2-related schwannomatosis - An update
    Moodley, Manikum
    Ortman, Chelsey
    SEMINARS IN PEDIATRIC NEUROLOGY, 2024, 52
  • [36] Giant sacral schwannoma in a neurofibromatosis type 2 patient
    Namdev Seth
    Dushyant Varshney
    Saumya Verma
    Egyptian Journal of Radiology and Nuclear Medicine, 54
  • [37] Giant sacral schwannoma in a neurofibromatosis type 2 patient
    Seth, Namdev
    Varshney, Dushyant
    Verma, Saumya
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2023, 54 (01)
  • [38] Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening
    Elisabeth Joye Petr
    Tobias Else
    Clinical Diabetes and Endocrinology, 4 (1):
  • [39] Topodiagnosis of deafness: strategy for treatment of neurofibromatosis type 2
    Marangos, N
    Stecker, M
    Laszig, R
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2000, 114 : 3 - 7
  • [40] Neurofibromatosis type 1
    Parada, LF
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1471 (01): : M13 - M19